Improving arm and hand function after stroke with clinically-relevant delivery of neurotrophin-3 to elderly disabled muscles: from rats to humans

Informazioni relative al progetto

StrokeTherapy

ID dell’accordo di sovvenzione: 309731

Progetto chiuso

Data di avvio 1 Novembre 2012

Data di completamento 31 Ottobre 2017

Finanziato da

• Specific programme: "Ideas" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)

Costo totale € 1 499 909,00

Contributo UE € 1 499 909,00

Coordinato da

KING'S COLLEGE LONDON
United Kingdom